ZyVersa Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Peter | Chief Financial Officer | Award / Grant | 3,000 | $2.88 | $8,640 | 44,585 | Dec 16, 2022 |
| INCON Co., Ltd. | — | Award / Grant | 1,497,199 | — | — | 1,497,199 | Dec 12, 2022 |
| Wolfe Peter | Chief Financial Officer | Award / Grant | 41,585 | — | — | 41,585 | Dec 12, 2022 |
| LaBella Nicholas A. Jr. | Chief Scientific Officer | Award / Grant | 18,094 | — | — | 18,094 | Dec 12, 2022 |
| Glover Stephen C. | Chief Executive Officer | Award / Grant | 43,847 | — | — | 43,847 | Dec 12, 2022 |
| O'Connor Daniel J. | — | Other | 1,377,598 | — | — | 1,377,598 | Dec 12, 2022 |
| A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. | — | Other | 3,427 | — | — | 446,843 | Mar 8, 2022 |
| A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. | — | Other | 49,730 | — | — | 450,270 | Feb 3, 2022 |
| Larkspur Health LLC | — | Other | 236,273 | — | — | 236,273 | Jan 6, 2022 |
| O'Connor Daniel J. | Chief Executive Officer | Other | 42,005 | — | — | 42,005 | Jan 6, 2022 |
| Briones David S. | Chief Financial Officer | Other | 10,752 | — | — | 10,752 | Jan 6, 2022 |